Trials / Recruiting
RecruitingNCT06837454
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to describe the therapeutic management of patients more than or equal to 18 years old eligible for systemic therapy or treated by systemic therapy for atopic dermatitis (AD). This study will be proposed to a sample of French dermatologists experienced in the management of AD, practicing in hospital centers and/or office-based dermatologists. The study will be conducted in real conditions of practice, systemic treatment decisions will be taken at the sole initiative of the participating physician irrespective of the patient enrollment decision. Each patient will be followed-up in routine care setting for 1 year.
Conditions
Timeline
- Start date
- 2025-02-04
- Primary completion
- 2027-05-13
- Completion
- 2027-05-13
- First posted
- 2025-02-20
- Last updated
- 2026-04-13
Locations
60 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06837454. Inclusion in this directory is not an endorsement.